Sleep Technology Is Moving Beyond Monitoring: ZenoWell Explores taVNS for Sleep Care

Thanksgiving 2026 Almanac Outlook Calls for Upper Midwest Snow and Eastern Rain as Travelers Plan AheadThe Old Farmer’s Almanac predicts snow in the Upper Midwest and rain in the East for Thanksgiving 2026. Here is how to plan travel safely and stay healthy. Cervical Cancer Screening Gaps Persist in the South and West as At-Home HPV Testing Expands for WomenA new study shows uneven cervical cancer screening across U.S. regions. Here are current Pap and HPV schedules and at-home testing options. Families with Children of Different Citizenship Status Can Check Each Child’s Eligibility for Medicaid or CHIP SeparatelyA JAMA Network Open study finds that over 1 million U.S. children live in families with mixed citizenship status. Learn how Medicaid and CHIP eligibility is decided for each child. Workers Offered CHOICE Health Allowances Should Compare Individual Plans, Networks, and Premiums Before Enrolling for 2027CHOICE Arrangements let employers fund individual health plans instead of group coverage. Learn the trade-offs before you choose a 2027 plan with your allowance. Mental Health National Depression Screening Advice Was Linked to More Therapy and Less Antidepressant-Only Use Among Distressed AdultsAfter depression screening became routine advice, distressed adults used more therapy and fewer antidepressants alone. What patients can ask. After Bend Elementary School Shooting, Oregon Officials Urge Families to Watch Children for Signs of Trauma and GriefAfter the Bend school shooting, Oregon officials urge families to check in with kids. Trauma signs by age and where to find help. Teens and Young Adults with Depression Had Four Times the Odds of a Prescription Drug Use DisorderYouths with depression had 4 times the odds of a prescription drug use disorder in a national survey. What parents should know about the findings. Ghost Networks Persist in Private Insurance as Fewer Than 1 in 4 Resolved Calls Booked Mental Health VisitsA JAMA Health Forum audit of 5,822 calls found fewer than 1 in 4 resolved calls to listed mental health clinicians led to an appointment. Innovation Patients with Bile Duct Cancer Need FGFR2 Testing Before Lirafugratinib, but the Label Lists No FDA-Authorized Companion TestLirafugratinib treats bile duct cancer with FGFR2 changes, but its label lists no FDA-authorized test. Learn what patients need for testing and eye checks. Breast Lump at 26 Revealed Cancer and a PALB2 Mutation in a Woman with No Known Family HistoryA woman found a breast lump at 26 with no known family history. Tests found cancer and an inherited PALB2 mutation. Here is what young women should know. CMS Official Admits Many Parts of Medicare’s AI-Assisted WISeR Prior Authorization Test in Six States Are Not WorkingA senior CMS official says many parts of Medicare’s AI-assisted WISeR prior authorization test are not working. See which services it covers and how patients can appeal. Older Adults at Fall Risk Had Modestly Fewer Falls When Clinics Could Prescribe Home Strength and Balance ExercisesA trial of 11,945 older adults found modestly fewer falls when clinics could prescribe home balance exercises. Here’s how families can ask. Healthy Living Social Security’s 3.6% Raise for 2027 Could Shrink Once a Projected $6.60 Medicare Part B Increase Is DeductedSocial Security’s 3.6% COLA adds about $75 a month, but a projected Part B increase could take $6.60 back. See what retirees can expect to keep in 2027. Parkview Health to Acquire Ovation Healthcare, Which Works with More Than 500 Health Care Organizations in 48 StatesParkview Health will acquire Ovation Healthcare, which works with more than 500 health care organizations in 48 states. See what the deal could mean for rural hospitals. Cutting Medicaid Adult Dental Benefits Would Save States Only 20 to 50 Cents for Every Dollar CutStates that cut adult Medicaid dental care keep only 20 to 50 cents per dollar because federal funds pay most costs, Harvard researchers report in JAMA Health Forum. Missouri Has Lost 11 Maternity Wards Since 2009 as Midwife Rules Push Some Providers to Practice in KansasMissouri has lost 11 maternity wards since 2009, and its nurse-midwife rules are pushing some providers to Kansas. See what it means for expectant families. Covid – 19 FDA Proposes Requiring Companies to Report Food Additives That Now Reach Grocery Shelves Without Federal ReviewFDA has released its proposed GRAS rule requiring companies to notify the agency about food additives. Here is what the proposal does and does not do. Federal Regulators Warn Some Hair Dryer Brushes Lack the Part That Stops ElectrocutionCPSC warns hair dryer brushes sold on Walmart.com and TikTok Shop lack immersion protection. The seller has not agreed to a recall or refund. A Recalled Teething Toy Broke the Pattern Parents Were Told to Look ForA newly recalled pull-string teething toy has a different model number and design from earlier recalls, and one choking incident has been reported. Trying to Lower Blood Sugar, Cholesterol or Blood Pressure? Different Workouts Suited Different MarkersA pooled analysis of 53 trials found that different exercise types helped different metabolic markers. Most of the evidence was low certainty. Share on TwitterShare on FacebookShare on Pocket[Berlin, Oct. 16, 2026] — Sleep technology has made sleep duration, sleep stages, and heart rate variability increasingly visible. But measuring sleep is only part of the challenge: understanding patterns does not always translate into actionable support.

Reflecting this shift, the European Sleep Research Society (ESRS) will introduce Sleep Technology as a standalone track at Sleep Europe 2026, highlighting growing interest in technology-enabled sleep assessment and care.

One emerging area is transcutaneous auricular vagus nerve stimulation (taVNS), a non-invasive approach that delivers electrical stimulation through the external ear to engage vagus nerve-associated pathways involved in autonomic regulation.

Clinical evidence for taVNS in sleep care is promising but preliminary. A 2024 randomized, sham-controlled trial published in JAMA Network Open reported improvements in sleep quality and insomnia severity among adults with chronic insomnia. A 2025 systematic review and meta-analysis of six studies involving 336 participants also found improvements, although the certainty of evidence was rated low to very low. A 2026 meta-analysis of 13 randomized controlled trials reported favorable sleep outcomes with tVNS more broadly.

Alongside clinical research, neuromodulation technology is exploring a shift from open-loop stimulation, which delivers preset stimulation, toward closed-loop approaches that use physiological signals to guide or adapt stimulation. A 2023 study by Szulczewski et al. investigated respiratory-gated taVNS, synchronizing stimulation with the breathing cycle. A 2024 pilot study by Tian et al. explored combining taVNS with slow breathing in people with insomnia. Together, these studies reflect growing interest in more physiologically responsive and individualized stimulation protocols.

Against this backdrop, the ZenoWell Luna Plus Set brings together three components to form an AI-guided closed-loop taVNS system: the Luna Plus Vagus Nerve Stimulator, ZenoBand MOBI, and the ZenoWell app with its Multimodal AI Coach. Built around three connected steps—Track, Understand, and Improve—the system represents an innovative approach to translating taVNS research into everyday home use.

The Luna Plus Set combines taVNS technology, wearable tracking, and sleep insights in one connected system. ZenoWell Track: Make Sleep Patterns VisibleThe ZenoWell app connects with ZenoWell wearables and compatible third-party devices, including Apple Watch and Oura Ring, bringing sleep data together in one place and turning overnight physiological signals into meaningful, understandable insights.

Powered by RAG technology and a curated database of vagus nerve research, ZenoWell’s Multimodal AI Coach combines wearable metrics, taVNS session logs, and daily context—including travel, late meals, and subjective check-ins—to identify potential sleep disruptors.

By analyzing changes around individual taVNS sessions and longer-term trends in heart rate, HRV, and sleep, it helps users understand their patterns and explore whether consistent use is associated with improvements over time, with personalized guidance on next steps.

The Luna Plus vagus nerve stimulator features a dedicated Sleep Mode with a 20-minute taVNS session designed for pre-bed use. Its approach combines research-informed stimulation parameters with respiratory-gated stimulation and physiological response monitoring, tracking changes in HR and HRV before, during, and after each session.

The technology draws on clinical research, including a 2024 randomized, sham-controlled trial by Zhang et al. that reported improvements in sleep quality and insomnia severity. While these findings provide a scientific basis for exploring taVNS in sleep care, further studies are needed to establish the efficacy of individual devices and stimulation protocols.

Building on this foundation, ZenoWell aims to advance personalized taVNS stimulation through AI, combining insights from clinical sleep datasets with individual physiological responses and user feedback to inform tailored stimulation parameters over time.

The ZenoWell app brings together wearable data, taVNS session logs, and AI-powered insights to help users explore sleep patterns and potential disruptors over time. ZenoWell A Connected Approach to Sleep CareFor sleep professionals, the integrated system offers a way to bring home-based routines, physiological trends, and user-reported experiences into follow-up discussions. It is intended as an adjunctive wellness tool, not a replacement for established care such as cognitive behavioral therapy for insomnia (CBT-I) or professional clinical judgment.

“ZenoWell has reached more than 100,000 users, many of whom are looking for support with sleep difficulties, and we have received positive feedback on our approach to sleep support,” said Dr. Jane, Founder & Chief Scientist at ZenoWell. “We believe sleep technology should go beyond measurement. By connecting physiological tracking, personalized insights, and a structured bedtime routine, we aim to help people better understand their sleep patterns and explore more individualized ways to support their well-being.”

ZenoWell will attend Sleep Europe 2026 in Maastricht, October 20–23, at Booth A75. Learn more about Luna Plus Set and its approach to sleep wellness at zenowell.ai.

Incubated at Heidelberg University Medical School, ZenoWell builds on the medical and research expertise of its parent company, BrainClos, which has developed closed-loop taVNS technology and contributed patents and research publications across areas including sleep, pain management, stroke rehabilitation, motor balance, and HRV. This research foundation supports ZenoWell’s development of non-invasive taVNS technology for autonomic nervous system regulation and personalized wellness. The company is also exploring more than 50 potential clinical and research collaborations.

Building on this foundation, ZenoWell offers the Luna Plus and Vita product lines, each designed for distinct user needs across sleep, stress recovery, pain management, metabolic health, focus, and mood regulation. Its products reach users through both wellness professional partnerships and direct-to-consumer channels.